Oscar Health Inc
$ 28.26
-2.25%
12 Jun - close price
- Market Cap 8,520,192,000 USD
- Current Price $ 28.26
- High / Low $ 28.86 / 27.52
- Stock P/E N/A
- Book Value 5.57
- EPS -0.54
- Next Earning Report 2026-08-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE -0.03 %
- 52 Week High 29.42
- 52 Week Low 10.69
About
Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States. The company is headquartered in New York, New York.
Analyst Target Price
$22.60
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-10 | 2025-11-06 | 2025-08-06 | 2025-05-07 | 2025-02-04 | 2024-11-07 | 2024-08-07 | 2024-05-07 | 2024-02-07 | 2023-11-07 | 2023-08-08 |
| Reported EPS | 2.07 | -1.24 | -0.53 | -0.89 | 0.92 | -0.62 | -0.22 | 0.2 | 0.62 | -0.66 | -0.29 | -0.07 |
| Estimated EPS | 1.1 | -0.92 | -0.5 | -0.89 | 0.81 | -0.58 | -0.18 | 0.16 | 0.27 | -0.7 | -0.47 | -0.16 |
| Surprise | 0.97 | -0.32 | -0.03 | 0 | 0.11 | -0.04 | -0.04 | 0.04 | 0.35 | 0.04 | 0.18 | 0.09 |
| Surprise Percentage | 88.1818% | -34.7826% | -6% | 0% | 13.5802% | -6.8966% | -22.2222% | 25% | 129.6296% | 5.7143% | 38.2979% | 56.25% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-05 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.34 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OSCR
2026-06-12 22:10:15
Oscar Health, Inc. (OSCR) stock declined by 2.25% in a recent trading session, underperforming the broader market despite a strong monthly gain of 24.88%. Investors are anticipating the company's upcoming earnings report, with expectations of significant EPS and revenue growth year-over-year. The stock currently holds a Zacks Rank #3 (Hold) and has a Forward P/E ratio of 61.51, which is a premium compared to its industry.
2026-06-10 20:40:00
Oscar Health shareholders re-elected all eight directors, approved executive compensation, and ratified PricewaterhouseCoopers LLP as the independent auditor at their 2026 Annual Meeting. This indicates strong support for the current leadership, pay practices, and financial oversight. An AI analyst from TipRanks rates OSCR as an "Outperform" due to improving financial quality and technical momentum.
2026-06-09 20:09:39
Oscar Health, Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected eight directors to serve until the 2027 Annual Meeting. They also approved the compensation of named executive officers in an advisory vote and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. The meeting achieved a quorum with over 820 million votes represented, reflecting strong shareholder participation and support for the proposals.
2026-06-08 20:39:58
Oscar Health director Laura W. Lang was granted 8,475 restricted stock units (RSUs) of Class A common stock at no cash cost. These RSUs vest on the earlier of one year from the grant date or the next annual stockholder meeting, contingent on continued service. Following this award, Lang's direct holdings in Oscar Health total 82,840 shares.
2026-06-08 20:39:58
Oscar Health director David Plouffe was granted 8,475 restricted stock units (RSUs) of the company's Class A common stock. These RSUs, which vest on the earlier of one year or the next annual stockholders' meeting subject to continued service, increase his direct holdings to 137,121 shares. The grant is valued at $0.00 per share and will be settled in Class A shares upon specific events after vesting.
2026-06-08 20:39:58
Oscar Health director Sid Sankaran has been granted 8,475 restricted stock units (RSUs) of Class A common stock, increasing his direct holdings to 22,609 shares. These RSUs vest on the earlier of one year from the grant date or the next annual stockholder meeting, contingent on his continued service. Additionally, 795,686 shares are held indirectly by Victoria Family LLC, for which Sankaran disclaims beneficial ownership except for his pecuniary interest.
